Social support from health care providers is associated with reduced illness intrusiveness in hemodialysis patients

Clinical Nephrology

Volumn 75, Issue 2, 2011, Pages 125-134

  Neri, L ^a,b   Brancaccio, D ^c   Rocca Rey, L A ^a   Rossa, F ^c   Martini, A ^d   Andreucci, V E ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fondazione Italiana del Rene Onlus   (Italy)

^d SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Hemodialysis; Quality of life; Social support

Indexed keywords

AGED; ARTICLE; FEMALE; HEALTH CARE DELIVERY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; ILLNESS INTRUSIVENESS RATING SCALE; ITALY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF EVALUATION; SOCIAL SUPPORT;

ADOLESCENT; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; COMMUNICATION; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; PERCEPTION; PROFESSIONAL-PATIENT RELATIONS; QUALITY OF LIFE; QUESTIONNAIRES; RENAL DIALYSIS; SOCIAL SUPPORT; YOUNG ADULT;

EID: 79251497042     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75125     Document Type: Article

References (30)

1. Devins GM, Mandin H, Hons RB et al. Illness intrusiveness and quality of life in end-stage renal disease: comparison and stability across treatmentmodalities. Health psychology: official journal of the division of health. Health Psychol. 1990; 9: 117-142.
2. Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006; 26: 68-79.
3. Devins GM. Illness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Adv Ren Replace Ther. 1994; 1: 251-263.
4. Devins GM. Using the Illness Intrusiveness Ratings Scale to understand health-related quality of life in chronic disease. J Psychosom Res. 2009; 68: 591-602.
5. Patel SS, Peterson RA, Kimmel PL. The impact of social support on end-stage renal disease. Semin Dial. 2005; 18: 98-102.
6. House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988; 241: 540-545.
7. Di Matteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004; 23: 207-218.
8. Kimmel PL, Peterson RA, Weihs KL et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998; 54: 245-254.
9. Helgeson VS. Social support and quality of life. Quality of Life Research. 2003; 12 (Suppl 1): 25-31.
10. Devins GM, Dion R, PelletierLGet al. Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings Scale. Med Care. 2001; 39: 1097-1104.
11. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004; 36: 717-731.
12. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008; 40: 879-891.
13. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull. 1996; 119: 488-531.
14. Wirtz PH, Redwine LS, Ehlert U, von Känel R. Independent association between lower level of social support and higher coagulation activity before and after acute psychosocial stress. Psychosom Med. 2009; 71: 30-37.
15. Christenfeld N, Gerin W. Social support and cardiovascular reactivity. Biomed Pharmacother. 2000; 54: 251-257.
16. HeinrichsM, Baumgartner T, Kirschbaum C, Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003; 54: 1389-1398.
17. Wirtz PH, von Känel R, Mohiyeddini C et al. Low social support and poor emotional regulation are associated with increased stress hormone reactivity to mental stress in systemic hypertension. J Clin Endocrinol Metab. 2006; 91: 3857-3865.
18. Leserman J, Petitto JM, Golden RNet al. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS.AmJ Psychiatry. 2000; 157: 1221-1228.
19. Berkman LF. The role of social relations in health promotion. Psychosom Med. 1995; 57: 245-254.
20. Frost C, Thompson SG. Correcting for regression dilution bias: comparison of methods for a single predictor variable. Journal of the Royal Statistical Society: Series A (Statistics in Society). 2000; 163: 173-189.
21. Lopes AA, Bragg-Gresham JL, Goodkin DA et al. Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res. 2007; 16: 545-557.
22. Rosas SE, Joffe M, Franklin E et al. Association of decreased quality of life and erectile dysfunction in hemodialysis patients. Kidney Int. 2003; 64: 232-238.
23. Manns B, Johnson JA, Taub K et al. Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol. 2003; 60: 341-351.
24. Kalantar-Zadeh K, Kuwae N,Wu DY et al. Associations of body fat and its changes over timewith quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006; 83: 202-210.
25. Kutner NG,DavinsGM.Acomparison of the quality of life reported by elderly whites and elderly blacks on dialysis. Geriatr Nephrol Urol. 1998; 8: 77-83.
26. Sesso R, Rodrigues-Neto JF, Ferraz MB. Impact of socio-economic status on the quality of life of ESRD patients. Am J Kidney Dis. 2003; 41: 186-195.
27. WuAW, Fink NE,Marsh-Manzi JVet al. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease-specific measures. J Am Soc Nephrol. 2004; 15: 743-753.
28. Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA. 1990; 263: 825-830.
29. Manns BJ, Johnson JA, Taub K et al. Dialysis adequacy and health related quality of life in hemodialysis patient. ASAIO J. 2002; 48: 565-569.
30. Chiu YW, Teitelbaum I, Misra M et al. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009; 4: 1089-1096.